CanSino Biologics Inc. (OTCMKTS:CASBF) Sees Large Drop in Short Interest

CanSino Biologics Inc. (OTCMKTS:CASBF) saw a large decrease in short interest in the month of February. As of February 15th, there was short interest totalling 10,800 shares, a decrease of 19.4% from the January 31st total of 13,400 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days.

CanSino Biologics Price Performance

CASBF remained flat at C$4.90 during trading on Tuesday. CanSino Biologics has a one year low of C$1.86 and a one year high of C$4.90. The firm has a fifty day moving average price of C$3.63 and a two-hundred day moving average price of C$3.39.

CanSino Biologics Company Profile

CanSino Biologics Inc develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N.